Abstract
A series of substituted pyrrolidine-2,4-dicarboxylic acid amides were synthesized as potential antidiabetic agents, and many of them showed good in vitro DPP-IV inhibition (IC50 = 2-250 nM) with selectivity over DPP-II, DPP8, and FAP enzymes. Selected compounds 8c and 11a showed in vivo plasma DPP-IV inhibition after oral administration in Wistar rats.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amides / chemical synthesis
-
Amides / chemistry*
-
Amides / pharmacology*
-
Animals
-
Dicarboxylic Acids / chemistry*
-
Dipeptidyl Peptidase 4 / metabolism*
-
Drug Design
-
Molecular Structure
-
Protease Inhibitors / chemical synthesis*
-
Protease Inhibitors / chemistry
-
Protease Inhibitors / pharmacology*
-
Pyrrolidines / chemistry*
-
Rats
-
Rats, Wistar
-
Structure-Activity Relationship
Substances
-
Amides
-
Dicarboxylic Acids
-
Protease Inhibitors
-
Pyrrolidines
-
pyrrolidine-2,4-dicarboxylic acid
-
Dipeptidyl Peptidase 4